LONG-TERM OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA (SIE 2026) - Oct 6, 2026 - Abstract #DP004; Pres time: Sep 21, 2026; 07:00 PM - 08:00 PM; Location: AREA POSTER; "POD24 was observed in 59% of the patients and 79% of them re- ceived Rituximab in first-line...Five and 10-year second-tumour incidence was 9.3% and 14%, re- spectively, without any significant impact of variables includ- ed in the univariate analysis. Long-term results of ASCT in FL showed that one-third of the patients may be potentially cured and they should be used as 'benchmark' for new avail- able therapies in young high-risk FL patients."
Follicular Lymphoma • Hematological Malignancies • Lymphoma • Transplantation
|
|
L. Meschia1,3; L. Farina1; G. Balestra1,3; S. Ljevar2; A. Guidetti1,3; A. Dodero1; A. Chiappella1; A. Barone1,3; M. Pennisi1; F. Stella1; L. Devizzi1; P. Matteucci1; P. Corradini1,3
|